Preskorn, Sheldon H <br/><br/>
Reboxetine: a norepinephrine selective reuptake pump inhibitor.  [electronic resource] 

 -  Journal of psychiatric practice  Jan 2004 
 - 57-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1527-4160 
<br/><br/><label>Standard No.: </label>10.1097/00131746-200401000-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Uptake Inhibitors--adverse effects<br/>Animals<br/>Antidepressive Agents--adverse effects<br/>Biological Availability<br/>Clinical Trials as Topic<br/>Cyclopropanes--adverse effects<br/>Depressive Disorder, Major--blood<br/>Drug Approval--legislation & jurisprudence<br/>Duloxetine Hydrochloride<br/>Humans<br/>Metabolic Clearance Rate<br/>Milnacipran<br/>Morpholines--adverse effects<br/>Reboxetine<br/>Thiazepines--adverse effects<br/>Thiophenes--adverse effects<br/>United States